Peanut Allergy Market Outlook: The Market Size ...

Over the last decades, organ transplantation has become the leading treatment option for patients with last-stage organ failure. However, although it has significantly reduced the mortality rate, specifically in life-threatening diseases such as end-stage kidney failure, recognition and eventual destruction of well...

Lilly, MiNA ink agreement to upregulate proteins using RNA Eli Lilly will utilise the power of MiNA Therapeutics’ proprietary small activating RNA (saRNA) technology platform to develop five novel drug candidates against diseases across the company’s core areas of focus. Eli Lilly declared a drug development ...

Arch Oncology scores USD 105 Million for anti-CD47 med in solid tumors, multiple myeloma Arch Oncology scored USD 105 million from new and old backers to expand the drug’s journey through the clinic and into new trials, having moved its anti-CD47 antibody into a phase 1/2 study.  Arch tests the drug alon...

Autoimmune and inflammatory diseases are common with a diverse array. Different organs are affected, and significant variability is seen among the individuals when talking about the severity, or the response to the treatment. Deregulated cytokine activity has a vital role in explaining autoimmune disease patho...

Chimeric Antigen Receptor (CAR) Therapies have changed the treatment paradigm of hematological malignancies to a vast extent. These personalized therapies have not only evolved as a game-changer in the field of medicine but also in the lives of the patients. Until the last approvals made by Novartis and Kite Pha...

An X-linked recessive disorder, Hemophilia occurs predominantly in males with females being the carriers. Patients diagnosed with Hemophilia usually lack one of the two proteins essential for the blood coagulation cascade namely factor VIII (FVIII) and factor IX (FIX). On the basis of the different blood coagulatio...